Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
ALBERT DAVID LIMITED	ALBERTDAVD	Bombay S.E. +1 Other	1,580	1,108 INR	Stock
ALBERT DAVID LIMITED	ALBERTDAVD	NSE India S.E.	10,037	1,108 INR
NINGBO DAVID MEDICAL DEVICE CO., LTD.	300314	Shenzhen S.E.	13,206,196	12.25 CNY	Stock
ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX DAVID GEGEN GOLIATH - NUR AKTIEN	LS9LPV	Berne S.E.	-	- CHF	Certificat
ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX DAVID GEGEN GOLIATH - NUR AKTIEN		Börse Stuttgart	-	191.8 EUR	Certificat

News (598)

Gold Reserve : Financial Statements	18/05	PU
Ipsen Announces Executive Changes	02/05	CI
Ipsen appoints Keira Driansky as EVP, President of North America	02/05	GL
Simon® Announces Exciting Additions to Woodbury Common Premium Outlets®	24/04	PR
Ipsen : Q1 2024 – sales presentation (1.17 MB)	24/04	PU
Transcript : Ipsen S.A., Q1 2024 Sales/ Trading Statement Call, Apr 24, 2024	24/04
Ipsen : Q1 2024 – sales announcement (228.28 KB)	24/04	PU
Ipsen : Q1 2024 – highlights (288.70 KB)	24/04	PU
Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance	24/04	GL
Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance	24/04	AQ
National Electronics Holdings Limited Announces Board Changes	26/03	CI
Phibro Animal Health Corporation to Participate in Barclays Global Healthcare Conference	01/03	BU
AZZ Inc. to Participate in Citi's 2024 Global Industrial Tech and Mobility Conference and J.P. Morgan's Global High Yield & Leveraged Finance Conference	09/02	PR
Transcript : Ipsen S.A., 2023 Earnings Call, Feb 08, 2024	08/02
Building on solid FY 2023 results, Ipsen anticipates four launches in 2024	08/02	GL
Building on solid FY 2023 results, Ipsen anticipates four launches in 2024	08/02	AQ
Milan fashion house Moschino taps Adrian Appiolaza as its new creative director	30/01	AQ
IPSEN : Ipsen outlined some promising mid-term takeaways at the CMD	08/12
Transcript : Ipsen S.A. - Analyst/Investor Day	07/12
Capital Markets Day 2023 - Ipsen outlines next phase of growth & transformation and provides new mid-term outlook	07/12	GL
Capital Markets Day 2023 - Ipsen outlines next phase of growth & transformation and provides new mid-term outlook	07/12	AQ
Transcript : Ipsen S.A. - Shareholder/Analyst Call	14/11
Gold Reserve : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K	27/23/27	PU
Transcript : Ipsen S.A., H2 2023 Earnings Call, Oct 26, 2023	26/23/26
Ipsen : YTD 2023 – sales presentation (1.04 MB)	26/23/26	PU
Ipsen : YTD 2023 – sales announcement (391.88 KB)	26/23/26	PU
Ipsen : YTD 2023 – sales highlights (299.07 KB)	26/23/26	PU
Ipsen delivers solid sales growth in the first nine months of 2023 and confirms its full-year guidance	26/23/26	GL
Ipsen delivers solid sales growth in the first nine months of 2023 and confirms its full-year guidance	26/23/26	AQ
Transcript : Alkermes plc, Q3 2023 Earnings Call, Oct 25, 2023	25/23/25
Stifel Independent Advisors Charts Future of Wealth Management at Three-Day Conference	11/23/11	PR
Transcript : On Holding AG - Analyst/Investor Day	04/23/04
MYT Netherlands Parent B : 9. Consolidated Financial Statements as of June 30, 2023 123 10. Separate Financial Statements as of June 30, 2023 174 - Form 6-K	19/23/19	PU
Ipsen appoints new R&D Director	01/23/01	CF
Ipsen announces change in R&D leadership: Howard Mayer to retire, succeeded by Christelle Huguet	01/23/01	GL
Ipsen announces change in R&D leadership: Howard Mayer to retire, succeeded by Christelle Huguet	01/23/01	AQ
Ipsen : appoints Mari Scheiffele as EVP and President, Specialty Care International	22/23/22	PU
Ipsen : Pledges Ambitious Action on Climate Change	22/23/22	PU
Ipsen : and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis, as part of a long-term global partnership	22/23/22	PU
UCB : Financial Reporting Document	28/23/28	PU
Transcript : Ipsen S.A., H1 2023 Earnings Call, Jul 27, 2023	27/23/27
Ipsen delivers solid H1 2023 results and upgrades its full-year guidance	27/23/27	GL
Artnet : Billionaire Art Collector Joe Lewis Indicted in New York for Insider Trading and Financial Fraud	27/23/27	PU
Transcript : Alkermes plc, Q2 2023 Earnings Call, Jul 26, 2023	26/23/26
Ipsen : CEO David Loew is elected to EFPIA leadership; joins industry partners to warn of impact of EU pharma legislation	23/23/23	PU

1234NextSee all

Companies (31)

LOEWS CORPORATION 16 550 M $

Loews Corporation is a holding company organized around 4 areas of activity: - insurance (84.6% of net sales; CNA Financial Corporation): primarily real estate insurance and damages; - operation of systems of gas conduits (10.3%; Boardwalk Pipeline); - ...

CHRISTIAN DIOR SE 140 B $

Christian Dior SE is a holding company organized around 6 areas of activity: - sale of fashion products and leather goods (48.9% of net sales): primarily Louis Vuitton, Fendi, Céline, Loewe, Givenchy, Kenzo, Thomas Pink, Berluti, Pucci and Loro Piana bra ...

LVMH 409 B $

LVMH Moët Hennessy Louis Vuitton SE is the world leader in luxury products. Net sales break down by family of products as follows: - fashion and leather items (48.9%): brands such as Louis Vuitton, Kenzo, Celine, Fendi, Marc Jacobs, Givenchy, etc.; - wa ...

DAVIDE CAMPARI-MILANO N.V. 12 452 M $

Davide Campari-Milano N.V. is one of the Italian's leading producers and distributors of spirits and wines. The activity is organized around three product families: - spirits: rhums, vodkas, tequilas, whiskies, liqueurs, etc. (Campari, SKYY Vodka, Cynar, ...

BARRATT DEVELOPMENTS PLC 6 312 M $

Barratt Developments PLC is one of the leading British builders of single-family homes. The group also develops and manages real estate properties. Net sales break down by activity as follows: - construction and sales of houses (98.4%): 17,206 houses bui ...

XENIA HOTELS & RESORTS, INC. 1 449 M $

Xenia Hotels & Resorts, Inc. is a self-advised and self-administered real estate investment trust (REIT) that invests in luxury and upper upscale hotels and resorts with a focus on the top 25 lodging markets as well as leisure destinations in the United S ...

MAGGIE BEER HOLDINGS LIMITED 19 M $

Maggie Beer Holdings Ltd is engaged in sale of branded premium food and beverage and gifting products in Australia and overseas markets. Its segments Maggie Beer Products Pty Ltd (MBP), Hampers & Gifts Australia Pty Ltd (HGA), and B.-d Farm Paris Creek Pt ...

DAN HOTELS LTD 578 M $

Dan Hotels Ltd is an Israel-based hotel chain which owns and operates 14 hotels throughout Israel, with a total of 3,874 rooms.The majority of the Dan Hotels are graded by the Ministry of Tourism as First Class hotels, the remainder as Tourist Class hotel ...

ALBA MINERAL RESOURCES PLC 7 M $

Alba Mineral Resources plc is engaged in the exploration and development of natural resources. The Company's mineral exploration portfolio is comprised of gold and, graphite, ilmenite, base metal and iron ore projects in a cluster of countries in northern ...

PRIME STRATEGY CO., LTD. 29 M $

Prime Strategy Co Ltd is a Japan-based company mainly engaged in the KUSANAGI Stack business. The KUSANAGI Stack Business segment consists of three main services: KUSANAGI Managed Services, Cloud Integration Services, and License Sales. The Company is als ...

1234Next

Insiders

David Loew

David G. Loew is Chief Executive Officer & Director at Ipsen SA and Chief Executive Officer at Ipsen Pharma SAS (a subsidiary of Ipsen SA). In the past he was Executive Vice President-Sanofi Pasteur at Sanofi and Global Head-Product Strategy at Genentech, Inc.

No results for this search